Literature DB >> 3970855

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

E N Harris, R A Asherson, A E Gharavi, S H Morgan, G Derue, G R Hughes.   

Abstract

Anticardiolipin antibody levels were determined in 116 patients with systemic lupus erythematosus and related autoimmune disorders. Forty-three of these patients had a history of thrombocytopenia--36 of whom had SLE, three primary Sjögren's syndrome, two rheumatoid arthritis and two mixed connective tissue disease. IgG anticardiolipin antibody levels were raised in 31 (72%) of the 43 patients and IgM anticardiolipin antibody levels were raised in 19 (44%). There was a strong statistical correlation between thrombocytopenia and raised anticardiolipin antibody levels of both the IgG (P less than 0.001) and IgM (P less than 0.01) immunoglobulin classes. Of the 20 patients with the highest IgG anticardiolipin antibody levels 16 had a history of thrombocytopenia. We suggest that anticardiolipin antibodies may play a direct role in mediating platelet destruction in autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970855     DOI: 10.1111/j.1365-2141.1985.tb02988.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  48 in total

1.  Antiphospholipid antibodies: which and when?

Authors:  R Cervera; J Font; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

2.  Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.

Authors:  Bum-Su Choung; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-03-17       Impact factor: 2.631

3.  Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease.

Authors:  T J Hendra; E Baguley; E N Harris; M H Khamashta; R C Trembath; G R Hughes; J S Yudkin
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

4.  Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  S Nomura; M Yanabu; T Fukuroi; H Kido; T Kawakatsu; K Yamaguchi; M Suzuki; T Kokawa; K Yasunaga
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

5.  Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.

Authors:  N J McHugh; D A Moye; I E James; M Sampson; P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

Review 6.  Evaluation of the obstetrical risks of the antiphospholipid syndrome and therapeutic management.

Authors:  P Edelman; A M Rouquette
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 7.  Antiphospholipid antibody syndrome: a review.

Authors:  P J Bingley; B I Hoffbrand
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

8.  IgG anti-cardiolipin antibodies in murine lupus.

Authors:  A E Gharavi; R C Mellors; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

9.  Calorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 mice.

Authors:  H Mizutani; R W Engelman; K Kinjoh; Y Kurata; S Ikehara; Y Matsuzawa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  The serology and immunochemistry of HIV-induced platelet-bound immunoglobulin.

Authors:  R J Klaassen; J van der Lelie; A B Vlekke; H M Weigel; J K Eeftinck Schattenkerk; P Reiss; A E von dem Borne
Journal:  Blut       Date:  1989-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.